Brief: Roivant Sciences Ltd. Says May Provide Additional Financing To Immunovant From Time To Time In Equity Investment, Issuer's Debt Securities, Loans
04/10/2023 23:05
Oct 4 (Reuters) - Immunovant Inc IMVT.O :
* ROIVANT SCIENCES LTD. SAYS MAY PROVIDE ADDITIONAL
FINANCING TO
IMMUNOVANT FROM TIME TO TIME IN EQUITY INVESTMENT, ISSUER'S DEBT
SECURITIES, LOANS
Further company coverage: IMVT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immunovant
See all newsU.S. STOCKS ON THE MOVE-Tesla, Blue Owl, Ford
Immunovant falls as drug for thyroid eye disease fails late-stage trials
Immunovant falls as eye disease therapy fails in late-stage studies
Immunovant Q3 net loss smaller than expected
Brief: Immunovant Q3 Net Income USD -110.635 Million Vs. IBES Estimate USD -125.1 Million